Cholinergic Receptor, Nicotinic Alpha 5 (CHRNA5) Peptide

Product Graph
175.5€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Cholinergic Receptor, Nicotinic Alpha 5 (CHRNA5) Peptide
category
Proteins and Peptides
provider
Abbexa
reference
abx616605
tested applications
P-ELISA

Description

Cholinergic Receptor, Nicotinic Alpha 5 (CHRNA5) Peptide is a synthetic peptide.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Cholinergic Receptor, Nicotinic Alpha 5 (CHRNA5)
Host
Synthetic
Recommended Dilution
BL (predicted): 0.5 mg/ml. Optimal dilutions/concentrations should be determined by the end user.
Conjugation
Unconjugated
Observed MW
Sequence Fragment: Internal region: C-HVDRYFTQKEET
Size 1
100 µg
Form
Lyophilized Reconstitute in deionized water.
Tested Applications
P-ELISA
Buffer
Prior to lyophilization: Deionized water.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Gene ID
1138
NCBI Accession
NP_000736.2
Background
Protein CHRNA5
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

Related Products
FNab01677
CHRNA5 antibody
After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.
Ver Producto
Pr22618
Recombinant Human NACHRA5
Ver Producto
abx001449
Cholinergic Receptor, Nicotinic Alpha 5 (CHRNA5) Antibody
CHRNA5 Antibody is a Rabbit Polyclonal antibody against CHRNA5. The protein encoded by this gene is a nicotinic acetylcholine receptor subunit and a member of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. These receptors are thought to be heteropentamers composed of separate but similar subunits. Defects in this gene have been linked to susceptibility to lung cancer type 2 (LNCR2).[provided by RefSeq, Jun 2010].
Ver Producto